Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion. Issue 1 (January 2017) - Diener, HC
Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed by rt-PA and/or thrombectomy in patients with ischemic stroke pre-treated with dabigatran. The use of idarucizumab followed by rt-PA is covered by the label of both drugs.